MedPath

Mcneil AB

Mcneil AB logo
🇸🇪Sweden
Ownership
Subsidiary
Established
1914-01-01
Employees
501
Market Cap
-
Website
http://www.mcneilab.se

Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.

Not Applicable
Completed
Conditions
Tobacco Dependence
Interventions
Drug: 6 mg Experimental nicotine gum
Drug: 4 mg Nicotine Gum/
Drug: 2 mg Nicotine Gum
First Posted Date
2010-11-04
Last Posted Date
2012-07-10
Lead Sponsor
McNeil AB
Target Recruit Count
24
Registration Number
NCT01234792
Locations
🇸🇪

McNeil AB Clinical Pharmacology R&D, Lund, Sweden

Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.

Not Applicable
Completed
Conditions
Tobacco Dependence
Interventions
Drug: Experimental Nicotine Replacement Therapy (NRT) 2 mg
Drug: Marketed Nicotine Lozenge
Drug: Experimental Nicotine Replacement Therapy (NRT)
First Posted Date
2010-10-25
Last Posted Date
2012-07-10
Lead Sponsor
McNeil AB
Target Recruit Count
104
Registration Number
NCT01227720
Locations
🇸🇪

Lund University Hospital Clinical Trial Unit, Lund, Sweden

🇸🇪

McNeil AB Clinical Pharmacology R&D, Lund, Sweden

Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® Gum

Not Applicable
Completed
Conditions
Tobacco Dependence
Interventions
First Posted Date
2010-06-29
Last Posted Date
2012-07-10
Lead Sponsor
McNeil AB
Target Recruit Count
19
Registration Number
NCT01152736
Locations
🇸🇪

McNeil AB Clinical Pharmacology R&D, Lund, Sweden

Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Gum

Not Applicable
Completed
Conditions
Tobacco Dependence
Interventions
First Posted Date
2010-06-29
Last Posted Date
2012-07-10
Lead Sponsor
McNeil AB
Target Recruit Count
76
Registration Number
NCT01152749
Locations
🇸🇪

McNeil AB Clinical Pharmacology R&D, Lund, Sweden

Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® Gum

Not Applicable
Completed
Conditions
Tobacco Dependence
Interventions
First Posted Date
2010-06-29
Last Posted Date
2012-07-10
Lead Sponsor
McNeil AB
Target Recruit Count
28
Registration Number
NCT01152723
Locations
🇸🇪

McNeil AB Clinical Pharmacology R&D, Lund, Sweden

Bioequivalence Between Nicotine Replacement Products and Nicorette® Gum

Not Applicable
Completed
Conditions
Tobacco Dependence
Interventions
First Posted Date
2010-04-29
Last Posted Date
2012-07-10
Lead Sponsor
McNeil AB
Target Recruit Count
88
Registration Number
NCT01113424
Locations
🇸🇪

Berzelius Clinical Research Center, Linköping, Sweden

To Test Bioequivalence Between Two Formulations of Paracetamol/Phenylephrine

First Posted Date
2010-04-28
Last Posted Date
2012-07-10
Lead Sponsor
McNeil AB
Target Recruit Count
40
Registration Number
NCT01112462
Locations
🇮🇪

Shandon Clinical Trials Ltd., Cork, Ireland

Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product

Not Applicable
Completed
Conditions
Tobacco Dependence
Interventions
Drug: Oral Nicotine
Drug: NiQuitinTM Nicotine Lozenge
Drug: Nicorette® Nicotine Gum
First Posted Date
2010-03-10
Last Posted Date
2012-07-13
Lead Sponsor
McNeil AB
Target Recruit Count
45
Registration Number
NCT01084603
Locations
🇸🇪

Clinical Pharmacology, Lund, Sweden

Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.

Not Applicable
Completed
Conditions
Tobacco Dependence
Interventions
First Posted Date
2010-03-10
Last Posted Date
2012-07-13
Lead Sponsor
McNeil AB
Target Recruit Count
40
Registration Number
NCT01084707
Locations
🇸🇪

Clinical Pharmacology, Lund, Sweden

Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge

Phase 2
Completed
Conditions
Smoking Cessation
Interventions
First Posted Date
2010-02-25
Last Posted Date
2012-07-10
Lead Sponsor
McNeil AB
Target Recruit Count
200
Registration Number
NCT01075659
Locations
🇸🇪

Clinical Pharmacology, Lund, Sweden

© Copyright 2025. All Rights Reserved by MedPath